BARCELONA, Spain--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced the Empirica™ Trace product, a significant new release of the company’s adverse event reporting software, formerly known as Clintrace™. With this new branding convention, Phase Forward is unifying its safety products under a new product family name – Empirica – for its suite of pharmacovigilance and risk management products. These products are managed by the company’s Lincoln Safety Group, one of the most experienced and respected teams in the safety industry.